Global Patient Registry Software Market- By Type of Registry (Disease Registry, Health Service Registry, and Product Registry), By Software (Standalone and Integrated), By Deployment Model (On-Premise and Web/Cloud-Based), By Database, By Functionality, By End-User, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast 2023-2032.

Report Overview

The Global Patient Registry Software Market size is expected to be worth around USD 3632 Million by 2032 from USD 1,200 Million in 2022, growing at a CAGR of 12% during the forecast period from 2023 to 2032.

An organized system that uses observational study methods to collect non-clinical or clinical patient data for the evaluation of specific outcomes is referred to as patient registry software. A population that is defined by a particular condition, disease, or exposure and serves predetermined scientific, clinical, or policy purposes is associated with these outcomes.

One of the main drivers of the market is the growing use of electronic health records (EHRs) and other eHealth solutions all over the world. The market’s expansion is accelerated by the rising incidence of chronic diseases like diabetes, cancer, and cardiovascular diseases, as well as the growing pressure to reduce healthcare costs and improve care quality. The market is further influenced by government initiatives to build patient registries and the widespread use of EHR solutions in healthcare practices to enhance service delivery.

The market also benefits from high disposable income, rising healthcare costs, advancements in healthcare infrastructure, an increase in the geriatric population, and the use of patient registry data for post-marketing surveillance. In addition, the development of cloud-based patient registry solutions and the rise of accountable care organizations offer market participants lucrative opportunities during the forecast period.

*Actual Numbers Might Vary In The Final Report

Key Takeaways

• Digital Transformation in Healthcare: Patient Registry Software Market Is Exploding: With healthcare’s digital revolution sweeping across healthcare systems worldwide, patient registry software adoption by providers to better manage data, streamline operations and maximize outcomes is growing significantly.
• Efficient Data Collection and Management: Patient registry software plays a significant role in efficient data collection, management, and analysis for healthcare organizations. By collecting patient information relevant to various conditions such as pain or illness management it assists with improved care delivery as well as research efforts or population health management programs.
• Diverse Applications: Software solutions used in diverse medical areas – chronic and rare illnesses, cancer, cardiovascular conditions – find applications with these software products, providing tracking for data tracking, surveillance of symptoms and evaluation of treatment outcome assessment.
• Real-World Evidence Generation for Research: Patient registry software has become an indispensable asset in clinical research and drug development, used by pharmaceutical companies and researchers alike for gathering real-world evidence on treatment effectiveness and safety among a real patient population.
• Interoperability and Data Sharing: Healthcare systems are evolving to promote interoperability and data sharing among themselves, so patient data can travel seamlessly among providers and institutions for coordinated care and research purposes. This ensures patient privacy is upheld.

Driving Factors

Initiatives by the Government to establish Patient Registries

Government agencies all over the world are taking steps to digitize and integrate healthcare systems, including the creation of computerized disease registries, in response to the growing demand for population health management and health information exchange.

In the United States, a number of federal and state agencies, in addition to the National Institutes of Health (NIH), the Agency for Toxic Substance and Disease Registry (ATSDR), the Centers for Medicare & Medicaid Services (CMS), the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), and the Agency for Healthcare Research and Quality (AHRQ) are concentrating their efforts on the creation of patient registries with the goal of determining the long-term outcomes of devices, agents, groups of drugs, or procedures.

Restraining Factors

Concerns about Data Security and Privacy

Due to a breach of a data registry that could potentially expose the confidential information of a large number of patients, the adoption of patient registry solutions is being hampered by concerns about data privacy and security. The number of healthcare data breaches has significantly increased in recent years. Medical identity theft accounts for approximately one-third of data breaches in the healthcare industry.

This is primarily attributable to a lack of internal control over patient information, outdated or non-adherence to existing policies and procedures, and inadequate employee training. The Identity Theft Resource Center’s 2019 breach list in the United States included 1,473 breaches, up 17% from the total number of breaches it tracked. 35.5% of all the breaches that were tracked belonged to the healthcare industry alone. The market might be hampered in some way by such risk factors.

Growth Opportunities

The Subscription Model has a High Rate of Adoption.

Since no IT staff is required, the subscription model places a minimal strain on healthcare systems and requires little upfront investment. Both efficiency and productivity are improved as a result. In addition, vendors can use this model to come up with novel licensing arrangements in order to reach new customers and prospects. Software with subscription models is increasingly being used by healthcare providers due to the shorter time it takes to implement new features.

The subscription model is currently being promoted by a number of market players because it provides more opportunities to establish trust and comprehend healthcare providers’ needs. During the forecast period, market participants are anticipated to receive growth opportunities due to these advantages.

Type of Registry Analysis

The Disease Registry Segment dominated the Market

The disease registry, health service registry, and product registry segments of the market for patient registry software are determined by the product. Cardiovascular disease, cancer, diabetes, asthma, rare diseases, and other diseases are further subdivided into the disease registry. The market was dominated by the disease registry segment, with a 38.7% revenue share. The segment is being driven by the rising demand to integrate the healthcare system and reduce disease burden. Additionally, they are useful for locating patients who are scheduled for clinical trials to discover new drugs.

Over the forecast period, it is anticipated that the product registry segment will experience profitable growth. During the post-approval phase of a drug or medical device, a registry is required for quality valuation once it has been approved by a regulatory authority in order to improve understanding of the safety of the product and recognize any adverse reactions. The segment is being propelled by a government initiative to improve treatment outcomes.

Software Analysis

The Standalone Segment Held the Highest Share of the Market

Due to its advanced features and user-friendly tools, the standalone software segment accounted for the highest share of 56%. The purpose of stand-alone software applications is to address cancer, diabetes, rare diseases, cardiovascular disease, and patient details. As a result, it is extremely detailed and easy to retrieve data.

Over the forecast period, it is also anticipated that an integrated segment will experience significant growth. An integrated system is a collection of software at the national level that allows for the tracking of affected areas and the evaluation of clinical intervention. Obtaining data on the burden of disease and treatment program efficacy will benefit even more from it. The program’s various integrated components, add-ons, and plugins are designed to work together perfectly, which is accelerating the market.

Deployment Model Analysis

The On-Premise Segment Holds the Largest Share

Due to its data security, ease of retrieval, and accessibility, the on-premise segment held the highest share of the market and was also useful for system upgrades and bulk data file transfers. Complete control over the premises and complete permission to access information are the primary reasons for the preference for these services. On-premise solutions are typically favored by pharma companies & research organizations because of the availability of individualized service options and the privacy of their data.

Due to its cutting-edge features, such as remote access to data and real-time tracking, web/cloud-based solutions are anticipated to grow profitably. Another benefit that is driving demand for this solution is incorporation in accordance with standard guidelines. Nowadays, cloud-based software is being preferred over on-premise software by both private and public organizations.

Database Type Analysis

The Commercial Segment accounted for the Highest Market Share

Due to its improved data security in comparison to the public database, the commercial segment of the market dominated with the highest revenue share. The fact that these databases adhere to coding and government standards is driving demand even higher. In addition, this software has a few benefits, including a single point of contact for any business issue, ease of use, and prompt software updates. Data exchange between government research organizations like the central disease registries and CDC is made possible by commercial systems, which is contributing to the segment’s expansion.

Over the forecast period, the type of public database is anticipated to experience profitable growth. The rising amount of research institutions is to blame for the expansion. The demand for this database is fueled by the fact that it is used for particular projects or research tasks. Additionally, the software is free of copyrights and patents.

Functionality Analysis

Population Health Management Dominated The Market For Patient Registry Software

Population health management accounted for the highest revenue share. The Fee-for-Service (FFS) model has been replaced by a Value-based Payment (VBP) model due to stakeholders’ growing demand for solutions that support value-based care delivery. PHM contributes to improving clinical outcomes, standardizing physician approaches, and lowering the price of disease management, all of which contribute to segment expansion.

Over the forecast period, the segment of medical research and clinical studies is anticipated to experience the most rapid growth. Patients with health issues typically have their data stored in these registries. It may occasionally include patient health status data for a particular treatment, which aids in the development of a new drug. Due to its real-time data and cost-effectiveness, the point-of-care market also has significant potential. The market for patient registry software is estimated to grow as a result of the above mentioned factors, which present enormous untapped opportunities.

End-User Analysis

The Government And Third-Party Segment Held The Largest Revenue Share

The market is divided into government and third parties, pharma & medical device companies, hospitals & medical practices, research organizations, and private payers. The government and third-party segments accounted for the majority of revenue. It is anticipated that the government’s use of this software to reduce disease burden in both developing and developed nations will fuel the market for patient registry software.

Over the forecast period, profitable growth is anticipated in the pharmaceutical and medical device companies segment. Growth is being fueled by biotech, pharmaceutical, and medical device companies’ adoption of this software to track real-world patient data. In addition, the data are useful for specific diseases and clinical trials. Due to these organizations’ efforts to reduce the global disease burden, the research organization sector is also anticipated to experience significant growth.

Key Market Segments

Based on the Type of Registry

• Disease Registry
• Cardiovascular
• Cancer
• Diabetes
• Rare disease
• Other Types of Disease Registry
• Health Service Registry
• Product Registry
• Medical Device
• Drug

Based on Software

• Standalone
• Integrated

Based on the Deployment Model

• On-Premise
• Web/Cloud-Based

Based on Database Type

• Commercial
• Public

Based on Functionality

• Population Health Management
• Product Outcome Evaluation
• Health Information Exchange
• Medical Research & Clinical Studies
• Patient Care Management
• Point-Of-Care

Based on End-User

• Government & Third Party
• Pharma & Medical Device Companies
• Hospitals & Medical Practices
• Research Organization
• Private Payers
• Other End-Users

Regional Analysis

North America Dominates the Global Patient Registry Software Market During the Forecast Period

The North American region is anticipated to experience significant growth during the forecast period, with the highest revenue share of 43% as a result of factors like the growing use of electronic health records, government initiatives to encourage the use of patient registry software, and pharmaceutical company R&D.

Over the forecast period, lucrative growth is anticipated in Asia-Pacific. Over the past few years, there has been an increase in the use of electronic medical records. Major factors driving the market in the region include the aging population, increased diagnostic errors, increased pressure to reduce medical errors, and increasing incidences of co-morbidities. The market for patient registry software is also expanding because of supportive government initiatives, particularly in China, South Korea, and Japan.

Key Regions

• North America
  • The US
  • Canada
  • Mexico
• Western Europe
  • Germany
  • France
  • The UK
  • Spain
  • Italy
  • Portugal
  • Ireland
  • Austria
  • Switzerland
  • Benelux
  • Nordic
  • Rest of Western Europe
• Eastern Europe
  • Russia
  • Poland
  • The Czech Republic
  • Greece
  • Rest of Eastern Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Australia & New Zealand
  • Indonesia
  • Malaysia
  • Philippines
  • Singapore
  • Thailand
  • Vietnam
  • Rest of APAC
• Latin America
  • Brazil
  • Colombia
  • Chile
  • Argentina
  • Costa Rica
  • Rest of Latin America
• Middle East & Africa
  • Algeria
  • Egypt
  • Israel
  • Kuwait
  • Nigeria
  • Saudi Arabia
  • South Africa
  • Turkey
  • United Arab Emirates
  • Rest of MEA

Key Players Analysis

Pulse Infoframe Partnered with Immunocore in Order to Introduce the First Global Patient Registry for Uveal Melanoma

The industry is characterized by the presence of numerous large and small players. Software for patient registries is in a highly competitive and fragmented market. For instance, Pulse Infoframe and Immunocore formed a partnership to launch the first global patient registry for uveal melanoma. Companies and academic institutions from the United States, Australia, and the United Kingdom are working together on this. The information obtained from the academic patient registry is expected to improve our understanding of the disease and help with future clinical research. A few major players in the market are Mckesson Corporation, Ifa Systems AG, Image Trend, Inc., Himagine Solutions Inc., CONDUENT Inc., Quintiles Inc., Onco Inc., Velos Inc., and other key companies.

Market Key Players

Listed below are some of the most prominent global patient registry software market players.

• IQVIA Inc.
• FIGmd, Inc.
• ImageTrend, Inc.
• Global Vision Technologies, Inc.
• Dacima Software Inc.
• Evado Clinical
• Syneos Health, Inc.
• ArborMetrix Inc.
• Other Key Players.

Key Industry developments

• In April 2022– Quantori, LLC established a Registry Science Practice with a primary focus on the development of registry programs for clinicians, patients, and researchers.
• In January 2022– The nation’s largest dynamic pancreatic patient disease database was developed partnership with Seqster and the National Pancreas Foundation (NPF). The database may be able to move advanced cutting-edge research more quickly than conventional methods.

Report Scope: